Fundraising Fox

Tiltbio

Helsinki, FI · 1 known investors

tiltbio.com ↗

TILT Biotherapeutics develops an investigational adenoviral immunotherapy platform for treating solid tumor cancers, with late-stage development of TILT-123 for head and neck cancer treatment. The company operates as a holding structure with distinct spin-out entities focused on clinical development and preclinical research.

BiotechHealthtechMedical Devices

Founders & leadership

AH
Akseli HemminkiFounder and CEO

Investors · 1

Lifeline Ventures✓ verified

In the news